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The disruption of myelin causes severe neurological diseases. An understanding of the mechanism of myelination and
remyelinationisessentialforthedevelopmentoftherapeutic strategies fordemyelinationdiseases.Ourprevious ﬁndings indicated
that the FcRγ/Fyn cascade is a potential therapeutic target for remyelination caused by the Chinese/Japanese traditional herbal
(Kampo) medicine ninjin’youeito (Ninjin-youei-to,NYT), which is a hot-water extract made from 12medicinal herbs. To identify
which constituents of NYT are involved in the reversal of demyelination and to examine the potential therapeutic eﬀect, we
tested several of the chemical constituents of NYT. Here, we report that Chinpi, a constituent of NYT, upregulates the FcRγ/Fyn
signaling cascade resulting in a potentially therapeutic eﬀect against age-induced demyelination. In addition, we observed that
phosphorylated (activated) FcRγ/Fyn upregulated the expression of the 21.5kDa isoform of myelin basic protein, inducing rapid
morphological diﬀerentiation, when oligodendrocyte precursor cells (OPCs) were cultured in the presence of hesperidin and/or
narirutin (themajoractive constituents ofChinpi).These results suggestthathesperidin andnarirutin participate in theFcRγ/Fyn
signalingpathway in OPCs causing these cells to diﬀerentiate into myelinating oligodendrocytes.
1.Introduction
The myelin sheath of the central nervous system (CNS) is
formed by oligodendrocytes wrapping layer upon layer of
theirownmembranesaroundaxonsinatightspiral,forming
an electrically insulating sheath around each axon. The
destruction of this myelin sheath in the CNS causes severe
neurological disorders [1–3]. Congenital dysmyelination
causes mental retardation in children, while demyelination
later in life results in a decline in cognitive function.
Elucidating the mechanism of demyelination/remyelination
should provide new insight for future therapeutic strategies
against dysmyelinating or demyelinating human diseases
such as multiple sclerosis (MS), although no therapy has
yet been established to prevent such disease progression
[4–6]. Although the reasons for the eventual failure of
remyelination (demyelinating diseases) are unknown, the
presence of oligodendrocyte precursor cells (OPCs) and
immature oligodendrocytes in some non-repairing lesions
suggests that these cells may fail to receive the necessary2 Evidence-Based Complementary and Alternative Medicine
diﬀerentiation signals [7–10]. Further elucidation of the
processes involved in OPC maturation may lead to new
therapeutic strategies for MS and other related diseases [11].
We previously demonstrated that the level of phosphory-
latedmyelin basic proteins(P-MBPs), especially the 21.5kDa
isoform, but not the level of total MBPs was markedly
and inversely correlated with demyelination induced by
aging and/or the neurotoxin cuprizone and that the low
levels of 21.5kDa P-MBP in demyelinated brain recovered
signiﬁcantly aftertreatment with aJapanese herbalmedicine,
Ninjin-youei-to (NYT) [12]. We hypothesized, therefore,
that the 21.5kDa P-MBP level might reﬂect the status
of myelination, indicating the levels of demyelination or
remyelination.
N Y Ti sah o t - w a t e re x t r a c tp r e p a r e df r o mam i x t u r eo f
several medicinal plants. A high-performance liquid chro-
matography (HPLC) analysis performed in our previously
report [12] conﬁrmed that the ingredients of the NYT water-
soluble extracts yielded a variety of peaks corresponding to
the chemical constituents of NYT: paeoniﬂorin and albi-
ﬂorin (from Peoniae radix, [Shakuyaku]); liquiritin, liquir-
itin apioside, isoliquiritin apioside, isoliquiritin and gly-
cyrrhizin (from Glyccyrrhizae radix, [Kanzo]); narirutin and
hesperidin (from Aurantii nobilis pericarpium, [Chinpi]);
cinnamaldehydeandcinnamicacid(fromCinnamomicortex,
[Keihi]); and 3,6 -disinapolysucrose (from Polygalae radix,
[Onji]). These peaks appeared at the appropriate retention
times and exhibited a dose-dependent correlation with the
concentration of the NYT solution. Surprisingly, the HPLC
analysis was particularly sensitive for detecting narirutin and
hesperidin, even at the lowest NYT concentrations.
NYT has not yet been approved as a therapeutic drug
for the recovery of age-induced demyelination (data not
shown). To further characterize the majoractive constituents
of NYT in the reversal of age-induced demyelination, the
constituents of NYT extract (made from 12 compounds)
were grouped into four mixtures based on the results of a
3D-HPLC analysis of NYT. The purpose of this study was to
investigate the accessibility of these eﬀective constituents of
NYT to areas of demyelinated brain after oral administration
and to determine the cellular and molecular mechanism
underlying the biological eﬃcacy of the major active con-
stituents of NYT.
2.Materialsand Methods
2.1. Mice. Twenty-six-month-old C57BL/6 mice were sup-
plied by the Department of Animal Science, Tokyo
Metropolitan Institute of Gerontology. Double-deﬁcient
(dKO) adult mice were obtained by crossing FcRγ-deﬁcient
[13] and Fyn-deﬁcient [14] mice, as described previously.
All the mice, including the mutants, were from a C57BL/6
background strain.
2.2. Animal Experiments. All the procedures used in this
study were in accordance with the guidelines of our institu-
tional animal care and use committee of Tokyo Metropolitan
Institute of Gerontology (approval No. 08045) and Keio
University School of Medicine (approval No. 08071).
2.3. Treatment with Ingredients Contained in NYT Extract.
NYT is a spray-dried extract of a mixture of 12 raw
medicinalplantsandismanufactured byKraciePharma,Ltd.
(Tokyo) under strict scientiﬁc and quality control protocols;
it has been approved for medical use by the Ministry of
Health, Labour, and Welfare of Japan. The compositions
of the plants and the 3D-HPLC proﬁle of NYT have been
previously reported [12, 15]. Here, we examined four groups
of NYT constituents. Using an age-induced demyelination
model, 1% of each constitutive herb was administered in
the drinking water of the animals for 2 months prior to
sacriﬁce. The constitutive herb mixtures were as follows: (i)
mixture A (Cinnamomi cortex [Keihi], 37.5g; Polygalae radix
[Onji], 30g; Peoniae radix [Syakuyaku], 30g; Aurantii nobilis
pericarpium [Chinpi], 30g; and Glyccyrrhizae radix [Kanzo],
15g), (ii) mixture B (Cinnamomi cortex [Keihi], 75g; and
Peoniae radix [Syakuyaku], 60g), (iii) mixture C (Polygalae
radix [ O n j i ] ,8 0 g ;a n dGlyccyrrhizae radix [Kanzo], 15g)
and (iv) mixture D (Aurantii nobilis pericarpium [Chinpi],
50g). A previously described method was used to perform
3D-HPLC analyses of these NYT constituents [12, 15].
Supplementary Figure 1 shows the results of the 3D-HPLC
analysis for Chinpi.
2.4. Tissue Preparation and Histopathological Analysis. Mice
(4-months old) were perfused with 4% paraformaldehyde
and their brains were ﬁxed overnight in an acid alcohol
solution(95% ethanol/5% acetic acid, v/v). The brain tissues
were then embedded in paraﬃn and sectioned into 10μm
thick slices. The sections were then mounted and stained
for myelin using Luxol Fast Blue (LFB: Acros Organics,
Fair Lawn, NJ, USA) solution (0.1% LFB in 95% ethanol
containing 0.05% acetic acid [Wako]; stained overnight
at 60◦C). Toluidine blue (Wako) staining was performed
according to the manufacturer’s protocol (Wako).
2.5. Electron Microscopy. Each cerebrumwas ﬁxed with 2.5%
glutaraldehyde and then post-ﬁxed with 1% OsO4.A f t e r
dehydration in ethanol, the specimens were embedded in
Quetol 812 (Nisshin EM, Tokyo, Japan). Ultrathin sections
stained with 2% uranylacetate and lead solution were
observed using a JOEL 100C electron microscope (JOEL,
Tokyo, Japan), as described elsewhere [12]. For the G-ratio
measurement (the ratio of the axon diameter to the diameter
of the axon plus the surrounding myelin), at least three
mice per group were used. Eight to ten microphotographs
of the corpus callosum (coronal) at midline and at a high
magniﬁcation (×5000, ×10000) were taken for each mouse,
and the G-ratios of at least 50 axons were measured. Axons
with aberrant morphology, such as myelin reduplication,
abnormal splitting of the myelin sheath, vacuolization of
the myelin lamellae, and myelin balloon formation, were
excludedbecause such aberrant myelin morphology makesit
impossible to evaluate the degree of myelination accurately.
Forexample,theextraordinarily largemyelin sheath ofaxonsEvidence-Based Complementary and Alternative Medicine 3
with an abnormal morphology arising from the repetition
ofunaccomplished remyelination should not be estimated in
the same manner as the myelin sheaths of normally devel-
oped myelinated axons. An additional quantitative study was
alsoundertakentoassessthenumberofmyelinated ﬁbersper
400μm2 using three mice per group (Figure 2).
2.6. Preparation of Myelin. Myelin was prepared as described
previously [12]. Brieﬂy, the cerebrum (0.2g) was homoge-
nized using a Teﬂon homogenizer in 20 volumes (w/v) of
0.32M sucrose and the resulting homogenate was layered
over 0.85M sucrose. After centrifugation at 25000r.p.m. for
30min, the layer of crude myelin layers was re-suspended
in water by homogenization and then washed by repeated
centrifugation. The homogenate was once again centrifuged
on a 0.85M sucrose bed, and the puriﬁed myelin was
removed.
2.7. Western Blot Analysis. The western blot analysis was
performed as described previously [12]. The membranes
were probed with polyclonal antibodies to FcRγ [13], Fyn
(Dr K. Senzaki, National Institute for Physiological Science,
Japan) and MBP (Nichirei, Tokyo, Japan), and monoclonal
antibodies to phosphotyrosine (PY20; Calbiochem), phos-
phorylated MBP (UpstateBiotechnology),actin (Sigma)and
CNPase (Sigma).Quantiﬁcation of the bands was performed
using densitometry and Image-J Software. Diﬀerences in the
amounts of loaded proteins among the lanes in a single
experiment were normalized according to the amount of
actin that was loaded.
2.8. OPC Culture and Stimulation. Mouse OPCs were
obtained from the cerebral hemispheres of embryonic day 17
mice. We cultured the mouse OPCs as previously described
[16]. Forthe stimulationexperiments, the OPCswere seeded
atadensityof1 ×106 cellsperplateandeachmixtureofNYT
constituent or ingredient compounds was added so that the
ﬁnal concentration of each compound was 10ng/mL. After
48h, the cells were harvested. The cell lysates were prepared
and SDS-PAGE and immunocytochemistry were performed
as previously described [16].
2.9. Immunoprecipitation and Immunoblotting. Cultured
OPCs were lysed in a solution containing 50mM Tris–
HCl (pH 7.4), 1% NP-40, 0.25% sodium deoxycholate,
150mM NaCl, 1mL EDTA-2Na, 1mM Na3VO4,1m MN a F ,
1mMPMSF ,2μg/mL aprotinin and 4μg/mL leupeptin(Cal-
biochem, LaJolla, CA, USA). The lysates were then puriﬁed
by centrifugation at 13000g. The protein concentration of
each lysate was measured using a micro BCA protein assay
reagent (PIERCE, Rockford, IL, USA). For immunoprecip-
itation, the lysates were incubated overnight at 4◦Cw i t h
anti-FcRγ and anti-Fyn polyclonal antibodies [11]a n da n t i -
phosphotyrosine (PY-20) monoclonal antibody, followed by
incubation for 2h at room temperature (RT) on a rotating
shaker with protein G sepharose (Amersham Biosciences,
Uppsala,Sweden).Thesampleswerewashedthreetimeswith
a solution containing 10mM Tris (pH 7.4), 150mM NaCl
and 0.05% Tween-20. The immunoprecipitated material was
centrifuged at 12 000g for 15min, and the resulting pellet
was washed once in washing buﬀer without Tween-20, then
resolved using SDS-PAGE (4–20% gradient polyacrylamide
gel) for 2h. The proteins were then electroblotted using
a semi-dry transfer onto an Immobilon PVDF membrane
(Millipore, Bedford, MA, USA). The membranes were
blockedwith5%skimmed milk(DifcoLaboratories,Detroit,
MA, USA) or 3% bovine serum albumin (for the phosphor-
antibodies) in Tris-buﬀered saline (TBS; pH 7.6) for 1h at
RT, and then the blots were incubated with several primary
antibodies for 2h at RT. Next, the membranes were washed
three times for 10min each using 1% skimmed milk in
TBS, were incubated with alkaline phosphatase-conjugated
goat anti-mouse or anti-rabbit IgG (diluted 1:800) for 2h
at RT, and were developed using nitro blue tetrazolium
(NBT) and 15-bromo-4-chloro-3-indolyl-phosphate (BCIP)
solution (both from Sigma, St Louis, MO, USA). The signal
bands were semi-quantiﬁed using the Kodak Electrophoresis
Documentation and Analysis System (EDAs) 290 (Eastman
Kodak Company, Rochester, NY, USA).
2.10. Statistics. Morphological data are shown as the mean
± SEM. Diﬀerences among groups were analyzed using the
Student t-test with a Bonferroni correction for multiple
comparisons. A value of P < .05 was considered statistically
signiﬁcant. Diﬀerences between NYT-treated samples and
their untreated counterparts were assessed using the Welch
t-test with a Bonferroni correction.
3.Results
3.1. Chinpi Ameliorates Age-Induced Demyelination via the
FcRγ/Fyn-MBP Cascade. To elucidate the active constituent
herbs of NYT, which is a hot-water extract of a combination
of12medicinalplants,theconstituentsofNYTweregrouped
into four mixtures and these mixtures were administered
to elderly mice for 2 months. After the treatment period,
t h et o t a lM B Pl e v e l si nt h eb r a i n so ft h em i c ew e r en o t
signiﬁcantly diﬀerent among the groups (mixtures A, B, C
and D).
For our initial evaluation of the ameliorating eﬃcacy of
the mixtures, an immunoblot analysis of the phosphorylated
and total MBPs was performed. In a previous study [12],
we demonstrated that the myelination status was closely
related to the levels of phosphorylated MBPs, especially to
that of the 21.5kDa isoform. The speciﬁc disappearance
and reappearance of 21.5kDa P-MBP occurred in paral-
lel with demyelination and remyelination in cuprizone-
and aging-induced demyelination models, while the total
MBP levels were not signiﬁcantly correlated with these
processes. In the present study as well, the amount of
phosphorylated 21.5kDa MBP (21.5kDa P-MBP), which
decreases as a result of age-induced demyelination, was
restored after treatment with mixtures A and D. Mixture
D was particularly eﬀective for restoring the 21.5kDa P-
MBP level (Figure 1). These results are consistent with those
of our previous report, which showed that NYT promotes4 Evidence-Based Complementary and Alternative Medicine
MBP
21.5
18.5
17
14
Actin
21.5
18.5
17
14
Treatment Water Water a b cd WaterWater abc d
26months 3months 26months 3months
∗ ∗ #
p-MBP
Figure 1: The 21.5kDa phosphorylated MBP (P-MBP) levels were closely related to the myelination status. Aging-induced demyelination
and its improvement by diﬀerent constituents of NYT were accompanied by the speciﬁc disappearance and reappearance of 21.5kDa P-
MBP protein, respectively. The levels of the 21.5-, 18.5-, 17- and 14-kDa isoforms (21.5, 18.5, 17 and 14) of total MBPs and P-MBP were
quantiﬁedusinganimmunoblotanalysisofisolatedmyelin sheaths.BecausethebasallevelsofP-MBPsandMBPsﬂuctuate duringaging,the
quantitative ratio of the four isoformswas calculated for each age. The quantiﬁcationand statisticalanalyseswere performed as described in
the ‘Materials and Methods’ section. Data represent the mean ± SEM (n = 3). ∗P < .005 versus untreated (3 months of water alone), #P <
.05 versus untreated. a: Mixture A (Keihi, Onji, Shakuyaku Kazo, Chinpi); b: Mixture B (Keihi, Shakuyaku); c: Mixture C (Onji, Kanzo); d:
Mixture D (Chinpi).
remyelination as shown by the reappearance of 21.5kDa P-
MBPaftercuprozone-inducedorage-induceddemyelination
[12].
We next used toluidine blue staining and electron
microscopy of the corpus callosum to examine the demyeli-
nation/remyelination status in elderly brain specimens after
treatment with Chinpi. Consistent with previous ﬁndings
obtained using a diet containing 1% NYT, feeding mice
with a diet containing 1% Chinpi for 2 months markedly
ameliorated the age-induced demyelination observed in 26-
month-old wild-type mice. While the brains of untreated,
elderly mice showed many abnormalities in the myelin
sheaths, such as myelin balloon formatiozn, splitting of the
myelin sheath, vacuolization of myelin lamellae, paranodal
retraction and abnormal tight junctions (abnormalities that
are rarely observed in younger mice); a marked reduction in
abnormal histological ﬁndings was observed in the brains
of elderly mice treated with 1% Chinpi in their drinking
water for 2 months (Figure 2). Furthermore, the density of
myelinated ﬁbers per 400μm2, which had decreased in the
26-month-old untreated mice, was restored after treatment
withChinpifor2months (Figure 2).The thin and shortened
myelin sheaths that are characteristic of remyelination can be
readily identiﬁed using electron microscopy to calculate the
G-ratio (the ratio of the axon diameter to the diameter of
the axon plus the surrounding myelin). In the elderly mice
that were treated with Chinpi for 2 months, the presence
of many small myelinated axons, which were presumed to
have arisen from remyelination, was observed (Figure 2).
The present data are consistent with the previously reported
ﬁnding that the myelination status was restored after 3 days
oftreatment with NYT in a demyelination model inducedby
5 weeks of cuprizone treatment [12]. These results suggest
that NYT promotes remyelination, rather than preventing
demyelination.
Our previous ﬁndings also suggested that the FcRγ/Fyn-
MBP cascade might be a potential therapeutic target of NYT
in the pathway leading to remyelination, since NYT pro-
moted myelination in wild-type mice but not in FcRγ/Fyn
dKO mice [12]. To further characterize the eﬃcacy of the
NYT constituents, we examined the eﬃcacy of the above-
mentioned mixtures of NYT constituents on the activation
of the FcRγ/Fyn cascade, which leads to myelination, using
wild-type and FcRγ/Fyn dKO mice. In particular, since the
ﬁrst partofthisstudyfocusedontherecoveryofthe21.5kDa
P-MBP level after treatment with mixture D (Chinpi), we
examined the eﬃcacy of Chinpi on FcRγ/Fyn dKO mice. An
immunoblot analysis of FcRγ, Fyn and MBP revealed that
Chinpi apparently upregulated the expressions of Fyn and
FcRγ in wild-type mice treated with either mixture A or D
( d a t an o ts h o w n )b u tt h a tt h e2 1 . 5k D aP - M B Pl e v e lw a sn o t
aﬀected by treatment with Chinpi in dKO mice nor was the
expression of the adult myelin marker CNPase signiﬁcantly
diﬀerent after Chinpi treatment (Figure 3).
To gain new insight into the molecular mechanisms
responsible for the eﬃcacy of Chinpi on the reversal of
demyelination, we also examined the eﬃcacy of Chinpi
treatmentinFcRγ/FyndKOmice.Thesemutantmiceexhibit
almost no change in phosphorylated/dephosphorylated
MBP levels during cuprizone-induced demyelination, and
previous observations have shown no signs of remyelination
arising from the reappearance of phosphorylated 21.5kDa
MBP and no electron microscopy evidence of remyelinated
ﬁbers, even after treatment with NYT for 2 months [12].
As expected, treatment with Chinpi had no eﬀect on the
levels of P-MBPs, including the 21.5kDa isoform (Figure 3),Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Suppression of age-induced demyelination by Chinpi. (A) Toluidine blue staining of cross-sections of the corpus callosum shows
age-induced demyelination in control mice (untreated) (a) and the reversal of age-induced demyelination in 26-month-old mice after
treatment withChinpifor2months(b).(B)Electron micrographsofcross-sectionsofthecorpus callosumshowage-induced demyelination
in 26-month old (a) mice. The myelination status was greatly improved after Chinpi treatment for 2 months (b). (C) The density of
myelinated ﬁbers per 400μm2 was lower in untreated 26-month-old mice, and treatment with Chinpi led to a signiﬁcant recovery in the
myelinated ﬁber density. The number of myelinated ﬁbers in each mouse was counted using 4–6 electron micrographs and was averaged.
Data represent the mean ± SEM(n = 3); ∗P < .005.(D) The G-ratio, an indicator ofdemyelinationdeﬁned asthe ratio ofthe diameter ofthe
axon to the diameter of the axon plus the surrounding myelin (the formula is shown in the insert), shows that the increased G-ratio in the
elderly mice was abrogated by Chinpi treatment. The number of measured axons determined from 3 to 5 mice per group was 54–109 using
8–10 electron micrographs per mouse. Data represent the mean ± SEM. P > .01 versus control.
in the dKO mice, even though these levels were increased by
treatment with mixtures A and D (Chinpi) in the wild-type
mice (data not shown).
3.2. Hesperidin and Narirutin Promote OPC Diﬀerentiation
via the Upregulation of 21.5kDa P-MBP. OPCs accumulate
during the depletionofmature oligodendrocytesordemyeli-
nation, and OPCs located near lesions begin to diﬀerentiate
and may actively participate in remyelination. Thus, the
stimulation ofOPCs couldserve as a valuabletool for repair-
ing functional damage caused by demyelination. Therefore,
we next tested whether FcRγ/Fyn signaling is stimulated
by NYT constituents in OPC culture. Although myelin
compaction cannot, at present, be modeled in an in vitro
experimental system, FcRγ/Fyn signaling is known to play
an extraordinarily important role in OPC diﬀerentiation/
myelination [11].Figure 4showsseveralconstituentsofNYT
and their eﬀectsonFcRγ/Fynsignaling in vitro;i np a r t i c u l a r ,
mixtures A (Keihi, Onji, Shakuyaku, Kanzo and Chinpi)
and D (Chinpi) dramatically activated FcRγ/Fyn signaling.
We also investigated the molecular and cellular mechanisms
underlying the potential eﬃcacy of hesperidin and narirutin,
chemical constituents of Chinpi, on FcRγ/Fyn signaling
using OPC cultures (Figure 5), with results that were similar
to those obtained using mixture A and D (Figure 4). Thus,
both hesperidin and narirutin, which are active compounds
ofChinpi, appear to activate the FcRγ/Fynsignaling pathway
leading to an increase in the 21.5kDa P-MBP level in
OPC cultures, which in turn activates modest morphological
diﬀerentiation (Figure 5). This observation is consistent
with previous ﬁndings showing that the FcRγ/Fyn level is
upregulatedbyseveralfoldsduringOPCdiﬀerentiation[11].6 Evidence-Based Complementary and Alternative Medicine
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Figure3:Chinpihadnotherapeutic eﬃcacyondemyelinationinFcRγ/Fyn double-deﬁcient mice(dKO).(A)LuxolFastBlue(LFB)staining
ofcross-sectionsofthe corpus callosumfrom untreated dKO mice (a),dKO mice after treatment withChinpi for2month(b) and 3-month-
old control mice (c). cc, corpus callosum; LV, lateral ventricle; GPI, globus pallidus (lateral segment); CP, caudate putamen; ﬁ, ﬁmbria;
CA3, ﬁeld CA3 in the hippocampus; int, internal capsule. (B) Immunoblot analysis of MBP and P-MBP levels from myelin in FcRγ/Fyn
double-deﬁcient (dKO) mice after treatment with Chinpi for 2 months. (a) Untreated control, (b) Chinpi treatment, (c) Normal control
mice (3-months old).
4.Discussion
The results of the present article support and extend our
previous ﬁndings showing a beneﬁcial eﬃcacy of NYT
treatment on aged-induced demyelination. Speciﬁcally, we
have shown that the recovery of demyelination in Chinpi-
treated elderlymice isassociated with an improvement in the
preservation ofmyelinated ﬁbers, asshown using an electron
microscopy analysis (Figure 2) .T h e s eﬁ n d i n g sa r ec o n s i s t e n t
with those of previous studies showing that recovery from
demyelination in cuprizone-treated and elderly mice is
achieved after the administration of NYT and suggesting
that the restoration of FcRγ/Fyn signaling is involved in
remyelination [12].
In general,each herbal constituentofa Kampo medicine,
such as NYT, is thought to play a particular role [17, 18],
with the various constituents working together to provide
the desired result. To further characterize the ameliorative
eﬃcacy of NYT on demyelinated brain, we investigated
the eﬃcacy of various mixtures of NYT constituents at
concentrations comparable to those achieved when NYT
is administered in drinking water. In this study, we suc-
ceeded in further isolating the active constituents of NYT.
Speciﬁcally, we showed that 2 months of treatment with an
orally administered hot-water extract of Chinpi (Aurantii
nobilis pericarpium) reversed age-induced demyelination in
mice (Figure 2). Moreover, this study also showed that the
FcRγ/Fyn signaling cascade plays a crucial and presumably
indispensable role in the compaction of the myelin sheath,
since FcRγ/Fyn double-deﬁcient (dKO) mice could not
recover from demyelination even after the administration
of Chinpi for 2 months (Figure 3). These ﬁndings suggest
that Chinpi may restore the FcRγ/Fyn cascade, leading to its
therapeutic eﬃcacy. Indeed, both narirutin and hesperidin,
the active constituents of Chinpi, are capable of activating
FcRγ-Fyn signaling (Figure 5). In addition, narirutin and
hesperidin dramatically increased the level of the 21.5kDa
P-MBP isoform, the regulation of which is known to
be correlated with demyelination/remyelination [12]. This
eﬀect is most likely achieved by hesperidin and narirutin
activating protein phosphorylation via an eﬀector kinase of
FcRγ/Fyn.
The consumption of dietary ﬂavonoids has been report-
edly associated with a reduced risk of neurodegenerative dis-
eases [19–21]. Hesperidin and narirutin are citrus ﬂavonoids
that are known to have a wide variety of pharmacological
activities [22, 23]. The mechanisms responsible for their
various actions have not yet been elucidated. Although the
bioavailability of the hesperidin and narirutin contained
in NYT is uncertain, several studies have suggested thatEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: NYT constituents enhance the activation of FcRγ-Fyn signaling in OPC cultures. The mixtures of NYT constituents were added
to the OPC cultures at a ﬁnal concentration of 10ng/mL for each constituent. After 48h, the cell lysates were immunoprecipitated using
anti-PY20 antibody and detected using anti-Fyn or anti-FcRγ antibody. The blots were probed with antibodies against anti-PY20 antibody
and re-probed with total Fyn or total FcRγ antibodies to normalize the mean intensity of phosphorylation. The phosphorylation of FcRγ
was greater in cells treated with mixtures A or D. (a) Untreated control OPCculture, (b) mixture A (Keihi,Onji,Shakuyaku,Chinpi,Kanzo),
(c) mixture B (Keihi, Shakuyaku), (d) mixture C (Onji, Kanzo), (e) mixture D (Chinpi).
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Figure 5: Chinpi’sactive constituents,hesperidinandnarirutin,activate theFcRγ/Fyn signalingcascadeandincreasethelevelof21.5kDa P-
MBPinOPCcultures. MixturesofNYTconstituentwereaddedtotheOPCcultures ataﬁnalconcentrationof10ng/mLforeachconstituent.
After 48h, the cell lysates were immunoprecipitated using anti-PY20 antibody and detected using anti-Fyn or anti-FcRγ antibodies. The
OPCs that had been incubated with hesperidin and/or narirutin showed signs of diﬀerentiation. The cells also showed a marked increase
in the level of 21.5kDa P-MBP. (N) narirutin; (H) hesperidin (Both are major constituents of Chinpi; see Supplementary Figure 1); (W)
narirutin plus hesperidin; (C) untreated control OPC cultures.8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Diagram of the proposed pathways by which hesperidin and naririutin, which are active ingredients of Chinpi, stimulate
the FcRγ/Fyn signaling cascade involved in remyelination. The activation of FcRγ/Fyn results in the upregulation of phospho-21.5kDa
MBP and the dramatic morphological diﬀerentiation of OPCs. OPC, oligodendrocyte precursor cells; OLGs, oligodendrocytes; P-MBP,
phosphorylated myelin basic protein.
orally administered citrus peel e x t r a c to rc i t r u sj u i c er e s u l t s
in the appearance of a substantial amount of ﬂavonoids
in the plasma [24–26]. In the present study, however, we
suggested that hesperidin and narirutin may act directly on
the reversal of demyelination in elderly mice via an eﬀect
on the FcRγ/Fyn signaling cascade, resulting in substantial
morphological diﬀerentiationwith the upregulationof MBP,
especially the 21.5kDa P-MBP.
In conclusion, the present study demonstrated that
Chinpi is the active ingredient in NYT responsible for
the reversal of age-induced demyelination and that Chinpi
stimulates the FcRγ/Fyn signaling cascade, resulting in the
diﬀerentiation of OPCs into myelinating oligodendrocytes
(Figure 6)[ 11]. Therefore, hesperidin and narirutin (which
are the active constituents of Chinpi) may have therapeutic
and physically potent eﬀects on various neurological disor-
ders in which demyelination plays a crucial role, including
MS, dementia and schizophrenia [27].
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Supplementary data are available at ECAM online.
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